PHARMACEUTICAL COMPOSITION COMPRISING PI3 KINASE INHIBITOR AND CYTOTOXIC ANTI-CANCER AGENT FOR PREVENTING OR TREATING CANCER

Title:

PHARMACEUTICAL COMPOSITION COMPRISING PI3 KINASE INHIBITOR AND CYTOTOXIC ANTI-CANCER AGENT FOR PREVENTING OR TREATING CANCER

Document Type and Number:

WIPO Patent Application WO/2019/139399

Kind Code:

A1

Abstract:

Provided is a pharmaceutical composition comprising a PI3 kinase inhibitor and a cytotoxic anti-cancer agent for preventing or treating cancer. The composition according to the present invention exhibits excellent cancer treatment effects compared to administration solely of a cytotoxic anti-cancer agent or a compound expressed by chemical formula 1 which has been used as a PI3 kinase inhibitor. Therefore, the composition according to the present invention can be effectively utilized to prevent, treat or ameliorate cancer.

More Like This:

WO/2021/203779	COMPOUND FOR TREATMENT OF PULMONARY ARTERIAL HYPERTENSION, AND APPLICATION THEREOF
JP2023052057	COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF LYMPHATIC SYSTEM DISORDERS
JP2022517113	New Substituted Sulfonylurea Derivatives

Inventors:

KIM NAM-HOON (KR)
KIM BAEKKYUNG (KR)
JEON BYEONGWOOK (KR)
SON MIKWON (KR)
CHOI YEONSEO (KR)

Application Number:

PCT/KR2019/000446

Publication Date:

July 18, 2019

Filing Date:

January 11, 2019

Export Citation:

Click for automatic bibliography generation Help

Assignee:

BORYUNG PHARM (KR)

International Classes:

A61K31/4184; A61K31/519; A61K31/704; A61P35/00

Domestic Patent References:

WO2014015675A1

2014-01-30

Foreign References:

KR20140020249A	2014-02-18
KR20160150006A	2016-12-28
KR20150079929A	2015-07-08
KR101653842B1	2016-09-02

Attorney, Agent or Firm:

AHN, So Young (KR)

Download PDF:

View/Download PDF PDF Help

Previous Patent: METHOD FOR PERFORMING COMMUNICATION ON BASIS OF POWER-SAVING OPERATION IN WIRELESS LAN SYSTEM, AND W...

Next Patent: APPARATUS AND METHOD FOR SCHEDULING IN WIRELESS COMMUNICATION SYSTEM